Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Res Clin Pract. 2021:109119. https://doi.org/10.1016/j.diabres.2021.109119.

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 Diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-53.

Mazze R. Advances in glucose monitoring: improving diabetes management through evidence-based medicine. Prim Care Diabetes. 2020;14(5):515-21. https://doi.org/10.1016/j.pcd.2020.03.001.

Ruiz Gracia T, García de la Torre Lobo N, Durán Rodríguez Hervada A, Calle Pascual AL. Structured SMBG in early management of T2DM: contributions from the St Carlos Study. World J Diabetes. 2014;5(4):471-81. https://doi.org/10.4239/wjd.v5.i4.471.

Draznin B, Aroda VR, Bakris G, et al. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Supplement_1):S97-s112. https://doi.org/10.2337/dc22-S007.

Stephen Colagiuri A, Hubert Kolb G, David Owens UK, Christopher Parkin US. Guidelines on self-monitoring of blood glucose in non-insulin treated Type 2 Diabetes. Available from: http://www.smbg-iwg.com. Accessed 23 Aug 2021.

Excellence NifhaC. Type 2 Diabetes in adults: management. Available from: http://www.nice.org.uk/guidance/ng28. Accessed 24 Nov 2021.

American Diabetes A. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S85-S99. https://doi.org/10.2337/dc21-S007.

Hou Y-Y, Li W, Qiu J-B, Wang X-H. Efficacy of blood glucose self-monitoring on glycemic control in patients with non-insulin-treated Type 2 Diabetes: a meta-analysis. Int J Nurs Sci. 2014;1(2):191-5. https://doi.org/10.1016/j.ijnss.2014.05.003.

Zhu H, Zhu Y, Leung SW. Is self-monitoring of blood glucose effective in improving glycaemic control in Type 2 Diabetes without insulin treatment: a meta-analysis of randomised controlled trials. BMJ Open. 2016;6(9):e010524. https://doi.org/10.1136/bmjopen-2015-010524.

Machry RV, Rados DV, Gregório GR, Rodrigues TC. Self-monitoring blood glucose improves glycemic control in Type 2 Diabetes without intensive treatment: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2018;142:173-87. https://doi.org/10.1016/j.diabres.2018.05.037.

Farmer A, Wade A, Goyder E, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ. 2007;335(7611):132. https://doi.org/10.1136/bmj.39247.447431.BE.

Article  PubMed  PubMed Central  Google Scholar 

O’Kane MJ, Bunting B, Copeland M, Coates VE. Efficacy of self monitoring of blood glucose in patients with newly diagnosed Type 2 Diabetes (ESMON Study): randomised controlled trial. BMJ. 2008;336(7654):1174-7. https://doi.org/10.1136/bmj.39534.571644.BE.

Kleefstra N, Hortensius J, Logtenberg SJJ, et al. Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC-17). Netherlands J Med. 2010;68(7-8):311-6.

Farmer AJ, Perera R, Ward A, et al. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated Type 2 Diabetes. BMJ. 2012;344:e486. https://doi.org/10.1136/bmj.e486.

Society CD. Clinical application guideline for blood glucose monitoring in China (2021 edition). Chin J Diabetes Mellitus. 2021;13(10):936-48.

Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, Randomized Trial. Am J Med. 2005;118(4):422-5. https://doi.org/10.1016/j.amjmed.2004.12.006.

Kempf K, Tankova T, Martin S. ROSSO-in-praxi-international: long-term effects of self-monitoring of blood glucose on glucometabolic control in patients with Type 2 Diabetes mellitus not treated with insulin. Diabetes Technol Ther. 2013;15(1):89-96. https://doi.org/10.1089/dia.2012.0213.

Parsons SN, Luzio SD, Harvey JN, et al. Effect of structured self-monitoring of blood glucose, with and without additional telecare support, on overall glycaemic control in non-insulin treated Type 2 Diabetes: the SMBG study, a 12-month randomized controlled trial. Diabet Med. 2019;36(5):578-90. https://doi.org/10.1111/dme.13899.

Polonsky WH, Fisher L, Schikman CH, et al. A structured self-monitoring of blood glucose approach in Type 2 Diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study. Diabetes Technol Ther. 2011;13(8):797-802. https://doi.org/10.1089/dia.2011.0073.

Barnett AH, Krentz AJ, Strojek K, et al. The efficacy of self-monitoring of blood glucose in the management of patients with Type 2 Diabetes treated with a gliclazide modified release-based regimen. a multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab. 2008;10(12):1239-47. https://doi.org/10.1111/j.1463-1326.2008.00894.x.

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.

Chircop J, Sheffield D, Kotera Y. Systematic review of self-monitoring of blood glucose in patients with Type 2 Diabetes. Nurs Res. 2021. https://doi.org/10.1097/nnr.0000000000000542.

Young LA, Buse JB, Weaver MA, et al. Glucose self-monitoring in non-insulin-treated patients with Type 2 Diabetes in primary care settings: a randomized trial. JAMA Intern Med. 2017;177(7):920-9. https://doi.org/10.1001/jamainternmed.2017.1233.

Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898.

Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-6. https://doi.org/10.1016/j.jclinepi.2010.07.015.

Deeks JJ HJ, Altman DG (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions.

Williams DM, Parsons SN, Dunseath GJ, Stephens JW, Luzio SD, Owens DR. The impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated Type 2 Diabetes: the SMBG study, a 12-month randomised controlled trial. Diabetes Metab Syndr. 2020;14(2):101-6. https://doi.org/10.1016/j.dsx.2020.01.006.

Suriyawongpaisal P, Tansirisithikul R, Sakulpipat T, Charoensuk P, Aekplakorn W. A participatory randomized controlled trial in knowledge translation (KT) to promote the adoption of self-monitoring of blood glucose for Type 2 Diabetes mellitus patients in an urban district of Thailand. J Med Assoc Thai. 2016;99(2):125-32.

Nishimura A, Harashima SI, Fujita Y, et al. Effects of structured testing versus routine testing of blood glucose in diabetes self-management: a randomized controlled trial. J Diabetes Complications. 2017;31(1):228-33. https://doi.org/10.1016/j.jdiacomp.2016.08.019.

Schwedes U, Siebolds M, Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care. 2002;25(11):1928-32. https://doi.org/10.2337/diacare.25.11.1928.

Sodipo OO, Adedokuna A, Olusola AA. Effect of self-monitoring of blood glucose on glycaemic outcome among type 2 diabetic patients. S Afr Fam Pract. 2017;59(6):208-13.

Durán A, Martín P, Runkle I, et al. Benefits of self-monitoring blood glucose in the management of new-onset Type 2 Diabetes mellitus: the St Carlos study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes. 2010;2(3):203-11. https://doi.org/10.1111/j.1753-0407.2010.00081.x.

Lu J, Bu RF, Sun ZL, et al. Comparable efficacy of self-monitoring of quantitative urine glucose with self-monitoring of blood glucose on glycaemic control in non-insulin-treated Type 2 Diabetes. Diabetes Res Clin Pract. 2011;93(2):179-86. https://doi.org/10.1016/j.diabres.2011.04.012.

Lee MK, Park CY, Park SW, Yoo SH, Lee KH, Lee DY. The effect of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with Type 2 Diabetes. Diabetes. 2017;66:A175.

Malanda UL, Bot SDM, Kostense PJ, Snoek FJ, Dekker JM, Nijpels G. Effects of self-monitoring of glucose on distress and self-efficacy in people with non-insulin-treated Type 2 Diabetes: a randomized controlled trial. Diabet Med. 2016;33(4):537-46. https://doi.org/10.1111/dme.12849.

Franciosi M, Lucisano G, Pellegrini F, et al. ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 Diabetes not receiving insulin. a pilot randomized clinical trial. Diabet Med. 2011;28(7):789-96. https://doi.org/10.1111/j.1464-5491.2011.03268.x.

Harashima S, Fukushima T, Sasaki M, et al. Self-monitoring of Blood Glucose (SMBG) improves glycaemic control in Oral Hypoglycaemic Agent (OHA)-treated Type 2 Diabetes (SMBG-OHA Study). Diabetes Metab Res Rev. 2013;29(1):77-84. https://doi.org/10.1002/dmrr.2363.

Guerci B, Drouin P, Grangé V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with Type 2 Diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) Study. Diabetes Metab. 2003;29(6):587-94. https://doi.org/10.1016/s1262-3636(07)70073-3.

Lee JY, Chan CKY, Chua SS, et al. Telemonitoring and team-based management of glycemic control on people with Type 2 Diabetes: a cluster-randomized controlled trial. J Gen Intern Med. 2020;35(1):87-94. https://doi.org/10.1007/s11606-019-05316-9.

Bosi E, Scavini M, Ceriello A, et al. Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated Type 2 Diabetes: the PRISMA randomized trial. Diabetes Care. 2013;36(10):2887-94. https://doi.org/10.2337/dc13-0092.

Kan K, Zhu W, Lu F, et al. Contribution of structured self-monitoring of blood glucose to the glycemic control and the quality of life in both insulin- and noninsulin-treated patients with poorly controlled diabetes. Diabet Technol Ther. 2017;19(12):707-14. https://doi.org/10.1089/dia.2017.0275.

Scherbaum WA, Ohmann C, Abholz HH, Dragano N, Lankisch M. Effect of the frequency of self-monitoring blood glucose in patients with Type 2 Diabetes treated with oral antidiabetic drugs-a multi-centre, Randomized controlled trial. PLoS One. 2008;3(8):e3087. https://doi.org/10.1371/journal.pone.0003087.

Xu Y, Tan DHY, Lee JY. Evaluating the impact of self-monitoring of blood glucose frequencies on glucose control in patients with type 2 Diabetes who do not use insulin: a systematic review and meta-analysis. Int J Clin Pract. 2019;73(7):e13357. https://doi.org/10.1111/ijcp.13357.

Mannucci E, Antenore A, Giorgino F, Scavini M. Effects of structured versus unstructured self-monitoring of blood glucose on glucose control in patients with non-insulin-treated Type 2 Diabetes: a meta-analysis of randomized controlled trials. J Diabetes Sci Technol. 2018;12(1):183-9. https://doi.org/10.1177/1932296817719290.

Poolsup N, Suksomboon N, Rattanasookchit S. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in Type 2 Diabetes patients: an update. Diabetes Technol Ther. 2009;11(12):775-84. https://doi.org/10.1089/dia.2009.0091.

American Diabetes Association Professional Practice C, American Diabetes Association Professional Practice C, Draznin B, et al. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Supplement_1):S97-S112. https://doi.org/10.2337/dc22-S007.

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-Year follow-up of intensive glucose control in Type 2 Diabetes. N Engl J Med. 2008;359(15):1577-89. https://doi.org/10.1056/NEJMoa0806470.

Article  PubMed  Google Scholar 

Mohan V, Ravikumar R, Poongothai S, et al. A single-center, open, comparative study of the effect of using self-monitoring of blood glucose to guide therapy on preclinical atherosclerotic markers in Type 2 Diabetic subjects. J Diabetes Sci Technol. 2010;4(4):942-8. https://doi.org/10.1177/193229681000400425.

Kalwat MA, Cobb MH. Mechanisms of the amplifying pathway of insulin secretion in the β cell. Pharmacol Ther. 2017;179:17-30. https://doi.org/10.1016/j.pharmthera.2017.05.003.

Castellana M, Parisi C, Di Molfetta S, et al. Efficacy and safety of flash glucose monitoring in patients with Type 1 and Type 2 Diabetes: a systematic review and meta-analysis. BMJ Open Diabetes Res Care. 2020;8(1). https://doi.org/10.1136/bmjdrc-2019-001092.

Price DA, Deng Q, Kipnes M, Beck SE. Episodic real-time CGM use in adults with Type 2 Diabetes: results of a pilot randomized controlled trial. Diabetes Ther. 2021;12(7):2089-99. https://doi.org/10.1007/s13300-021-01086-y.

Park C, Le QA. The effectiveness of continuous glucose monitoring in patients with Type 2 Diabetes: a systematic review of literature and meta-analysis. Diabetes Technol Ther. 2018;20(9):613-21. https://doi.org/10.1089/dia.2018.0177.

Gandhi GY, Kovalaske M, Kudva Y, et al. Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol. 2011;5(4):952-65. https://doi.org/10.1177/193229681100500419.

Krakauer M, Botero JF, Lavalle-González FJ, Proietti A, Barbieri DE. A review of flash glucose monitoring in Type 2 Diabetes. Diabetol Metab Syndr. 2021;13(1):42. https://doi.org/10.1186/s13098-021-00654-3.

Yeh HC, Brown TT, Maruthur N, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med. 2012;157(5):336-47. https://doi.org/10.7326/0003-4819-157-5-201209040-00508.

Adolfsson P, Parkin CG, Thomas A, Krinelke LG. Selecting the appropriate continuous glucose monitoring system - a practical approach. Eur Endocrinol. 2018;14(1):24-9. https://doi.org/10.17925/ee.2018.14.1.24.

Ehrhardt NM, Chellappa M, Walker MS, Fonda SJ, Vigersky RA. The effect of real-time continuous glucose monitoring on glycemic control in patients with Type 2 Diabetes mellitus. J Diabetes Sci Technol. 2011;5(3):668-75. https://doi.org/10.1177/193229681100500320.

Fonda SJ, Graham C, Munakata J, Powers JM, Price D, Vigersky RA. The cost-effectiveness of real-time continuous glucose monitoring (RT-CGM) in Type 2 Diabetes. J Diabetes Sci Technol. 2016;10(4):898-904. https://doi.org/10.1177/1932296816628547.

Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in Type 1 Diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011;343:d3805. https://doi.org/10.1136/bmj.d3805.